Skip to main content
Premium Trial:

Request an Annual Quote

Capsulomics, Johns Hopkins Partner on Esophageal Cancer, Barrett's Esophagus Research

NEW YORK – Startup Capsulomics and Johns Hopkins University announced on Tuesday a partnership on a clinical research study to detect esophageal cancer and Barrett's esophagus (BE).

Funded by a five-year, $3.7 million National Institutes of Health grant awarded in August 2018, the group plans to commercialize an assay that it believes is cheaper and less invasive than standard upper endoscopies.

BE normally develops when mucosal cells lining the lower section of the esophagus abnormally develops in patients. However, clinicians only identify BE by using invasive endoscopy and examining tissue from the space with a tissue biopsy.

Founded by CEO Daniel Lunz and Stephen Meltzer, a gastroenterology and hepatology professor at JHU, Capsulomics has developed a technology that integrates a sponge-based collection tool and a methylated-bead PCR method to detect BE.

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.